FOXM1 activated RRM2 drives poor outcomes in major PC subtype classifications (PCS and PAM50 classifiers),and targeting RRM2 and its key TFs (e.g. FOXM1) abrogate PC progression.
Processed, QC-approved and normalised (gcrma, GcRmaBackgroundCorrection) expression data from dataset GSE30521 used in "The Transcriptomic Landscape of Prostate Cancer Development and Progression: An
Supplementary Material 2: Supplementary Table 2: List of differential gene expressed in PCa tumor tissues (PC) Vs non-tumor tissues (HC) and relative p-value.